HEALTH PROFESSIONAL · SOURCE READING

Treatment Options for ET

Source: Myeloproliferative Neoplasms Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 27, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Essential Thrombocythemia

Treatment options for ET include:

No treatment, unless complications develop, if patients are asymptomatic, younger than 60 years, and have a platelet count of less than 1,500 × 109/L.

Hydroxyurea.[13]

Source links and citations

Interferon alfa [20-23] or pegylated interferon alfa-2a.[24,25]

Source links and citations

Anagrelide.[26,27]

Source links and citations

Continue within this section

Hydroxyurea →

Publication references

Read the original reference and check its publication notices.

PubMed 1731512 · Original source
PubMed 19826111 · Original source
PubMed 23782935 · Original source
PubMed 28291640 · Original source
PubMed 7700286 · Original source
PubMed 8574158 · Original source

Preserved source evidence · Not medical advice